MDR1rs1045642多态和乳腺癌风险之间的关联:更新的元分析
Lili Gong1, Gang Hu1, Lihua Xu1
1Department of Breast Surgery Center, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430016, P.R. China.
Oncology letters
|March 11, 2024
概括
MDR1 rs1045642基因多态性与整体乳腺癌风险无关. 然而,它可能会增加亚洲人群的风险,并在混合种族中降低风险.
科学领域:
- 遗传学 遗传学 是一个
- 在瘤学瘤学.
- 药物基因组学 药物基因组学
背景情况:
- 多药耐药性1 (MDR1) 基因编码了一个依赖ATP的排泄,这对于癌症治疗中药物运输至关重要.
- 已经研究了MDR1基因的突变,特别是rs1045642多态,以确定它们与癌症发病率的潜在关联.
- 之前对MDR1rs1045642多态和乳腺癌风险的研究已经产生了不一致的结果.
研究的目的:
- 使用元分析系统地评估MDR1rs1045642多态和乳腺癌风险之间的关联.
- 为了澄清关于MDR1 rs1045642多态性及其对乳腺癌易感性影响的相互矛盾的发现.
主要方法:
- 对21个已发表的病例研究进行了元分析,其中包括6815名乳腺癌患者和9227名健康对照.
- 分析了截至2023年8月16日的数据,以评估MDR1 rs1045642多态与乳腺癌风险的整体和子组关联.
- 统计分析包括赔率比率 (OR),95%置信区间 (CI) 和异质性评估 (I2).
主要成果:
- 总的来说,MDR1 rs1045642多态性与乳腺癌风险没有显著关联.
- 亚组分析显示,在具有TT基因型的亚洲人群中,乳腺癌风险明显更高 (递归模型:OR=1.393,P=0.001).
- 在混合种族人群中,MDR1 C3435T多态性与乳腺癌发病率降低有关 (OR=0.578,P=0.006),但在白人中并非如此.
结论:
- 在不同族群中,MDR1 rs1045642多态可能会对乳腺癌风险产生不同的影响.
- 在亚洲人群中观察到潜在的风险增加,而在混合种族群体中观察到风险降低.
- 在高加索人群中没有发现任何显著的关联,这凸显了乳腺癌研究中需要进行特定种族的遗传分析的需要.
更多相关视频
相关概念视频
Mismatch Repair
4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K
Single Nucleotide Polymorphisms-SNPs
15.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K


